On February 3, 2017, the company announced that it had completed the acquisition of Citron Pharmaceuticals, Inc. ("Citron"), a company that manufactures and sells generic pharmaceuticals.  The company's second quarter earnings call was conducted by Jody Burfening, Chief Operating Officer, and Sal Guccione, Chief Financial Officer.  The company's financial results for the second quarter of fiscal 2017 were impacted by the acquisition of Citron.  According to the company's press release, the acquisition of the Citron product lines and related assets resulted in a significant decline in the company's second quarter net income.  The company's second quarter net income was $30.8 million, a decrease of $14.1 million compared to the second quarter of 2016.  The company's third quarter net income was $32.2 million, a decrease of $4.6 million compared to the prior year's quarter.  The company's third quarter net income is $32.2 million, a drop of $4.6 million from the second quarter.  The company's revenue for the period ending June 30, 2016 was $125.6 million, a decrease of $4 million from $131.7 million reported in the second quarter of fiscal 2016.  The company's second quarter net income for the second quarter was $30.8 million, a drop of $14.1 million compared to $35.9 million in the second quarter of 2016.  The company is now on track to realize annual SG&A synergies of approximately $4 million by the end of fiscal 2018.  The company's financial results for the period ending June 30, 2016 were impacted by supply interruptions on two of our product lines.  The company's third quarter net income for the second quarter was $16.9 million, a 22% decrease from the prior year.  The company's third quarter net income in the second quarter was $32.2 million, a 22% decrease from the second quarter.  The company's fourth quarter net income was $34.1 million, a 22% decrease from the second half of 2016.  The company's third-quarter net income in the second quarter was $32 million, a decrease of $4 million.  The company's third-quarter gross income was $36 million, a decrease of $8 million.  The company's fourth quarter net income in the second half of fiscal 2016 was $32 million.  The company's third quarter net income declined 9.3% to $34.5 million.  The company's third-quarter net loss was $4.2 million.  The company's third quarter net loss was $32 million.  The company's